About: Marcel Lebel

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Marcel Lebel Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

doctor and university professor

Attributes	Values
rdf:type	Item
description	médecin et professeur d'université (fr) doctor and university professor (en)
rdfs:label	Marcel Lebel (en) Marcel Lebel (fr) néphrologues (es) néphrologues (nl)
skos:prefLabel	Marcel Lebel (en) Marcel Lebel (fr) néphrologues (es) néphrologues (nl)
name	Marcel Lebel (en) Marcel Lebel (fr) néphrologues (es) néphrologues (nl)
Scopus author ID	wds:Q75131540-bc13136d-4b09-fbe6-8d42-6aff1fd69ced
Scopus author ID	10339241000
given name	wds:Q75131540-521ae95a-4820-8cfb-6753-5043c425a4b9
given name	Marcel
instance of	wds:Q75131540-395d5400-43d3-d92d-95c0-a9b83ada7acd
instance of	Homo sapiens
award received	wds:Q75131540-5611868c-41ea-3e71-0fd8-4907fce14efc
award received	emeritus
ResearchGate profile ID	wds:Q75131540-d08331c3-4d85-4c85-fee0-f8caf22c9039
ResearchGate profile ID	Marcel_Lebel
occupation	wds:Q75131540-5bdb970e-47c5-abb3-b3e4-a04ae8bf4196 wds:Q75131540-a4b4b34a-48eb-4b65-4e57-453e64921087
employer	wds:Q75131540-8b7c95aa-4072-cc15-2924-90e26f3bfdbe
sex or gender	wds:Q75131540-83399110-46dd-cd1d-f7c4-5b4a905bcd28
educated at	wds:Q75131540-750aad8d-4291-6849-29ef-3f7a44924dca wds:Q75131540-ee55cdc0-426e-d45e-10f4-d23ded859e32 wds:Q75131540-fa95726c-47db-e071-f3bf-dd9f962aa2a9
family name	wds:Q75131540-fc7c745f-4bae-c05a-c754-97be205eebd9
occupation	nephrologist university teacher
employer	Laval University
sex or gender	male
educated at	Université de Montréal University of Glasgow Laval University
family name	Lebel
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q75131540
is author of	Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin Relationship between eicosanoids and endothelin-1 in the pathogenesis of erythropoietin-induced hypertension in uremic rats A patient with a juxtaglomerular cell tumor with histological vascular invasion The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of risk. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part I - blood pressure measurement, diagnosis and assessment of risk Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension The 2001 Canadian recommendations for the management of hypertension: Part one--Assessment for diagnosis, cardiovascular risk, causes and lifestyle modification The 2001 Canadian recommendations for the management of hypertension: Part two--Therapy Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats Functional tests for primary aldosteronism: value of captopril suppression Endothelin-1 in chronic renal failure and hypertension Role of oxidative stress in erythropoietin-induced hypertension in uremic rats Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats Determinants of progression of aortic stiffness in hemodialysis patients: a prospective longitudinal study. eNOS gene delivery prevents hypertension and reduces renal failure and injury in rats with reduced renal mass. 2009 Canadian Hypertension Education Program recommendations: the scientific summary--an annual update The impact of arteriovenous fistulas on aortic stiffness in patients with chronic kidney disease The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension Active renin mass concentration to determine aldosterone-to-renin ratio in screening for primary aldosteronism Morning plasma aldosterone predicts the subtype of primary aldosteronism independent of sodium intake The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of risk 2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations The 2011 Canadian Hypertension Education Program Recommendations for the Management of Hypertension: Blood Pressure Measurement, Diagnosis, Assessment of Risk, and Therapy The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of risk Vascular remodeling and media calcification increases arterial stiffness in chronic kidney disease Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock Hypertension in dialysis and kidney transplant patients Atherosclerotic renovascular disease The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk Increased ET-1 and reduced ET(B) receptor expression in uremic hypertensive rats Effect of erythropoietin on blood pressure and on the vascular endothelial ET-1/ETB receptor system Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats Acute effects of cinacalcet on arterial stiffness and ventricular function in hemodialysis patients: A randomized double-blinded crossover study Effects of TGF-beta1 on endothelial factors. Endothelin-1 levels and cardiovascular risk factors in renal transplant patients
is author of	wds:Q34633365-F24CDDE4-4C3C-4A64-964B-BA6D379EF9CB wds:Q37253885-EE0EBBDF-C6FF-4856-A9EB-C0FB49EC4F90 wds:Q38286863-5B0EB220-806F-4DCA-ACA6-63A43BE2C60F wds:Q35754537-FEAA20AE-1B28-4EC2-B4B9-2036DA4166F5 wds:Q46691716-5829B3FF-6F6F-4907-98CC-7876AE637AEB wds:Q44210656-5104C779-D23D-4D1D-8E56-7AB7CD79693B wds:Q28183032-752158F3-BC7A-4D1D-9A2C-6BC3601403C7 wds:Q34727966-F70DD5F6-8666-44A5-AD98-B6C9D0193030 wds:Q37253882-5D7EC77D-C8AA-47F7-9AC9-1A99B4E6ABAF wds:Q38010883-DAFDE711-1199-46B0-80ED-610E72F1C2D2 wds:Q83769834-2F3AB6E1-3E6E-4EB6-8928-8960A52E8B30 wds:Q34661652-EEA39C4A-3002-4D95-A0CC-A4722BD87DF0 wds:Q43167304-DEC97D3B-8199-4D24-A41A-B01A7F754C5F wds:Q43216561-C8C43318-7FB5-4D0B-8C74-E5A99444B3B4

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software